4//SEC Filing
Seres Therapeutics, Inc. 4
Accession 0001209191-15-057775
$MCRBCIK 0001609809operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 12:49 PM ET
Size
8.8 KB
Accession
0001209191-15-057775
Insider Transaction Report
Form 4
NESTLE SA
10% Owner
Transactions
- Award
Common Stock, $0.001 par value
2015-07-01$18.00/sh+1,333,333$23,999,994→ 6,888,888 total(indirect: See Footnote)
NIMCO US, Inc.
10% Owner
Transactions
- Award
Common Stock, $0.001 par value
2015-07-01$18.00/sh+1,333,333$23,999,994→ 6,888,888 total(indirect: See Footnote)
Transactions
- Award
Common Stock, $0.001 par value
2015-07-01$18.00/sh+1,333,333$23,999,994→ 6,888,888 total(indirect: See Footnote)
Footnotes (1)
- [F1]Held by Nestle Health Science US Holdings, Inc. Nestle Health Science US Holdings, Inc. is a wholly owned subsidiary of NIMCO US, Inc., which is a wholly ownd subsidiary of Nestle S.A., a publically traded company. Each of these entities may be deemed to share voting and investment power with respect to all shares held by Nestle Health Science US Holdings, Inc. Each of the filing entities disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609809
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 12:49 PM ET
- Size
- 8.8 KB